Cipher Pharmaceuticals Inc.
CPHRF
$12.00
-$0.56-4.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.33M | 17.36M | 12.14M | 9.25M | 11.55M |
| Total Depreciation and Amortization | 7.22M | 6.94M | 7.07M | 5.55M | 4.02M |
| Total Amortization of Deferred Charges | 159.00K | 153.00K | 136.00K | 99.00K | 61.00K |
| Total Other Non-Cash Items | -10.21M | -5.61M | -5.35M | -4.44M | -5.03M |
| Change in Net Operating Assets | 5.23M | 11.04M | 7.14M | 10.88M | 8.95M |
| Cash from Operations | 29.73M | 29.88M | 21.13M | 21.33M | 19.55M |
| Capital Expenditure | -28.00K | -10.00K | -80.03M | -80.04M | -80.04M |
| Sale of Property, Plant, and Equipment | 130.00K | 130.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -173.00K | -80.00K | -- | -- | -- |
| Cash from Investing | -71.00K | 40.00K | -80.03M | -80.04M | -80.04M |
| Total Debt Issued | -- | 0.00 | 40.00M | 40.00M | 40.00M |
| Total Debt Repaid | -35.31M | -27.29M | -15.33M | -281.00K | -233.00K |
| Issuance of Common Stock | 215.00K | 101.00K | 66.00K | 80.00K | 152.00K |
| Repurchase of Common Stock | -5.38M | -3.72M | -2.14M | 0.00 | -176.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -49.00K | -447.00K | -447.00K | -447.00K |
| Cash from Financing | -40.47M | -30.96M | 22.15M | 39.35M | 39.30M |
| Foreign Exchange rate Adjustments | 473.00K | -63.00K | 111.00K | -625.00K | -786.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.34M | -1.10M | -36.65M | -19.98M | -21.99M |